Eric W. Bleickardt
Impact in
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 29
- Chronic Myeloid Leukemia Treatments 18
- Multiple Myeloma Research and Treatments 11
- Genetics 16
- Chronic Lymphocytic Leukemia Research 16
- Co-authors
- Hagop Kantarjian (9 shared papers)Neil P. Shah (6 shared papers)Jörge E. Cortes (7 shared papers)Charles L. Sawyers (7 shared papers)John M. Nicoll (5 shared papers)Claude Nicaise (4 shared papers)Tai‐Tsang Chen (2 shared papers)Moshe Talpaz (4 shared papers)
- Journals
- Blood (15 papers)New England Journal of Medicine (3 papers)British Journal of Haematology (2 papers)Cancer (2 papers)Transplantation and Cellular Therapy (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Eric W. Bleickardt
36 papers receiving 5.7k citations
Eric W. Bleickardt's Hit Papers
Peers
Comparison fields: 5 of 83
- Hematology 4.5k
- Genetics 2.2k
- Rheumatology 1.4k
- Oncology 1.8k
- Molecular Biology 1.4k
Countries citing papers authored by Eric W. Bleickardt
This map shows the geographic impact of Eric W. Bleickardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric W. Bleickardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric W. Bleickardt more than expected).
Fields of papers citing papers by Eric W. Bleickardt
This network shows the impact of papers produced by Eric W. Bleickardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric W. Bleickardt. The network helps show where Eric W. Bleickardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric W. Bleickardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias Hit paper breakdown → | 2006 | 1437 |
| 2 | Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Hit paper breakdown → | 2010 | 1290 |
| 3 | Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma Hit paper breakdown → | 2015 | 1112 |
| 4 | 2008 | 420 | |
| 5 | Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma Hit paper breakdown → | 2020 | 348 |
| 6 | 2008 | 201 | |
| 7 | 2016 | 199 | |
| 8 | 2009 | 186 | |
| 9 | 2015 | 141 | |
| 10 | 2017 | 119 | |
| 11 | 2015 | 65 | |
| 12 | 2009 | 52 | |
| 13 | 2016 | 41 | |
| 14 | 2009 | 32 | |
| 15 | 2021 | 31 | |
| 16 | 2014 | 30 | |
| 17 | 2008 | 26 | |
| 18 | 2002 | 21 | |
| 19 | 2005 | 21 | |
| 20 | 2007 | 21 |
About Eric W. Bleickardt
Eric W. Bleickardt is a scholar working on Hematology, Genetics, Rheumatology, Oncology and Molecular Biology, having authored 36 papers that have together received 5.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (11 papers), Eosinophilic Disorders and Syndromes (10 papers), CAR-T cell therapy research (5 papers), Peptidase Inhibition and Analysis (5 papers), Protein Degradation and Inhibitors (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Hematology (4.5k citations), Genetics (2.2k citations), Rheumatology (1.4k citations), Oncology (1.8k citations) and Molecular Biology (1.4k citations). Eric W. Bleickardt has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Hagop Kantarjian, Neil P. Shah, Jörge E. Cortes, Charles L. Sawyers, John M. Nicoll, Claude Nicaise, Tai‐Tsang Chen, Moshe Talpaz, Andreas Hochhaus and Nicholas J. Donato. Their work appears in journals such as Blood, New England Journal of Medicine, British Journal of Haematology, Cancer and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.